The University of Arkansas for Medical Sciences (UAMS) has received a 5-year federal grant for nearly $2.2 million to study ...
Corneal cross-linking (CXL) has transformed the disease course of patients with corneal ectasias since its introduction to ...
Unlocking the potential of donor scleral tissue: Innovations and future applications. When organs are donated, it is with the ...
The report urges the US Department of Health and Human Services, in collaboration with departments of education at the state ...
Diana Do, MD, spoke with the Ophthalmology Times team about her presentation at the Retina Society meeting focusing on Population Pharmacokinetic Modeling and Simulation of Ocular Clearance for ...
According to the company, topline results will be presented at the 2024 American Academy of Ophthalmology Annual Meeting, ...
The announcement marks the second FDA designation for ATSN-201, which previously received Rare Pediatric Disease designation.
The acquisition strengthens the company’s rare disease segment, and adds 2 durable commercial assets, Iluvien and Yutiq with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback